Mercator Medsystems, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.mercatormed.com
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
- Conditions
- Thrombosis, Deep VeinIliofemoral; Thrombosis
- Interventions
- Combination Product: Perivascular dexamethasoneCombination Product: Perivascular sham
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04862468
- Locations
- 🇺🇸
Vascular Care Connecticut, Darien, Connecticut, United States
🇺🇸University of South Florida, Tampa, Florida, United States
🇺🇸Northwestern University Hospital, Chicago, Illinois, United States
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT
- Conditions
- Iliofemoral; Thrombosis
- Interventions
- Combination Product: Perivascular shamCombination Product: Perivascular dexamethasone
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04858776
- Locations
- 🇺🇸
St John Health System, Bartlesville, Oklahoma, United States
🇺🇸Stony Brook University Hospital, Stony Brook, New York, United States
🇺🇸CardioVoyage, Denison, Texas, United States
Temsirolimus Adventitial Delivery to Improve ANGioplasty And/or Atherectomy Revascularization Outcomes Below the Knee
- Conditions
- Peripheral Artery DiseaseCritical Limb Ischemia
- Interventions
- Drug: Saline placeboDrug: Temsirolimus
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT04433572
Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
- Conditions
- Peripheral Arterial Disease
- Interventions
- First Posted Date
- 2019-05-08
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03942601
- Locations
- 🇺🇸
Arkansas Heart Hospital, Little Rock, Arkansas, United States
🇺🇸Columbia University Medical Center/NYPH, New York, New York, United States
🇺🇸St. Joseph Hospital of Orange Heart and Vascular Center, Orange, California, United States
Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)
- First Posted Date
- 2016-09-20
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02908035
- Locations
- 🇺🇸
Sanford Research, Sioux Falls, South Dakota, United States
🇺🇸Advocate Christ Medical Center, Oak Lawn, Illinois, United States
🇺🇸St. Joseph Hospital of Orange Heart and Vascular Center, Orange, California, United States
Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization
- Conditions
- Chronic Limb Ischemia
- Interventions
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2020-02-19
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT02479620
- Locations
- 🇺🇸
Holy Name Medical Center, Teaneck, New Jersey, United States
🇺🇸Arkansas Heart Hospital, Little Rock, Arkansas, United States
🇺🇸Hattiesburg Clinic, Hattiesburg, Mississippi, United States
Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization
- Conditions
- Chronic Limb Ischemia
- Interventions
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2020-02-20
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT02479555
- Locations
- 🇩🇪
Universitätsklinikum Leipzig AöR, Leipzig, Germany
🇩🇪Universitäts-Herzzentrum Freiburg Bad Krozingen GmbH, Bad Krozingen, Germany
🇩🇪Medinos Kliniken des Landkreiss Sonneberg GmbH, Sonneberg, Germany
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
- Conditions
- Peripheral Arterial Disease
- Interventions
- Device: Atherectomy SystemDevice: Balloon Angioplasty
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT02469532
- Locations
- 🇺🇸
Hattiesburg Clinic, Hattiesburg, Mississippi, United States
🇺🇸Arkansas Heart Hospital, Little Rock, Arkansas, United States
🇺🇸Endovascular Technologies (Willis Knighton Medical Center), Bossier City, Louisiana, United States
Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
- Conditions
- Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2014-02-19
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02066103
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Duke University, Raleigh, North Carolina, United States
🇺🇸The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
- Conditions
- Peripheral Arterial Diseases
- Interventions
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Mercator MedSystems, Inc.
- Target Recruit Count
- 285
- Registration Number
- NCT01983449
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸Rutgers New Jersey Medical School, Newark, New Jersey, United States
🇺🇸Wellmont CVA Heart Institute, Kingsport, Tennessee, United States